Carmen Pérez-García

Carmen Pérez-García

Auto-generated profile, based on publicly available information

Carmen Pérez-García

Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28925, Alcorcón, Madrid, Spain

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2017 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
RFRosalía Fernández-Calle
Rosalía Fernández-Calle
MVMarta Vicente-Rodríguez
Marta Vicente-Rodríguez
EGEsther Gramage
Esther Gramage
JPJimena Pita
Jimena Pita
CPCarmen Pérez-García
Carmen Pérez-García
Gonzalo HerradonGonzalo Herradon
Gonzalo Herradon
Pleiotrophin (PTN) is a cytokine found highly upregulated in the brain in different disorders characterized by overt neuroinflammation such as neurodegenerative diseases, drug addiction, traumatic injury, and ischemia. In the present work, we have explored whether PTN modulates neuroinflammation and if Toll-like receptor 4 (TLR4), crucial in the initiation of an immune response, is involved. In immunohistochemistry assays, we studied lipopolysaccharide (LPS, 7.5 mg/kg i.p.)-induced changes in glial fibrillary acidic protein (GFAP, astrocyte marker) and ionized calcium-binding adaptor molecule 1 (Iba1, microglia marker) expression in the prefrontal cortex (PFC) and striatum of mice with transgenic PTN overexpression in the brain (PTN-Tg) and in wild-type (WT) mice. Cytokine protein levels were assessed in the PFC by X-MAP technology. The influence of TLR4 signaling in LPS effects in both genotypes was assessed by pretreatment with the TLR4 antagonist (TAK-242, 3.0 mg/kg i.p.). Murine BV2 microglial cells were treated with PTN (0.5 μg/ml) and LPS (1.0 μg/ml) and assessed for the release of nitric oxide (NO). We found that LPS-induced microglial activation is significantly increased in the PFC of PTN-Tg mice compared to that of WT mice. The levels of TNF-α, IL-6, and MCP-1 in response to LPS were significantly increased in the PFC of PTN-Tg mice compared to that of WT mice. Pretreatment with TAK-242 efficiently blocked increases in cytokine contents in a similar manner in both genotypes. Concomitant incubation of BV2 cells with LPS and PTN significantly potentiated the production of NO compared to cells only treated with LPS. Our findings identify for the first time that PTN is a novel and potent regulator of neuroinflammation. Pleiotrophin potentiates LPS-stimulated microglia activation. Our results suggest that regulation of the PTN signaling pathways may constitute new therapeutic opportunities particularly in those neurological disorders characterized by increased PTN cerebral levels and neuroinflammation.


18 February 1999 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
CPCarmen Pérez-García
Carmen Pérez-García
LMLydia Morales
Lydia Morales
MCM. Victoria Cano
M. Victoria Cano
ISIsabel Sancho
Isabel Sancho
LAL. F. Alguacil
L. F. Alguacil

1 May 2001 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
LMLydia Morales
Lydia Morales
CPCarmen Perez‐Garcia
Carmen Perez‐Garcia
LALuis F Alguacil
Luis F Alguacil

1 January 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MPMiryam Pastor
Miryam Pastor
RFRosalía Fernández-Calle
Rosalía Fernández-Calle
BGBruno Di Geronimo
Bruno Di Geronimo
MVMarta Vicente-Rodríguez
Marta Vicente-Rodríguez
JZJosé María Zapico
José María Zapico
ARAna Ramos
Ana Ramos

1 October 2019 in Neuroscience
Verified
Journal Article
Closed access
ACAna Contreras
Ana Contreras
EPEduardo Polín
Eduardo Polín
MMMiguel Miguéns
Miguel Miguéns
CPCarmen Pérez-García
Carmen Pérez-García
VPVicente Pérez
Vicente Pérez
NONuria Del Olmo
Nuria Del Olmo